{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:50Z","timestamp":1791235430470,"version":"4.1.0"},"reference-count":41,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0505","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T22:03:12Z","timestamp":1557352992000},"page":"637-645","source":"Crossref","is-referenced-by-count":17,"title":["High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men"],"prefix":"10.1507","volume":"66","author":[{"given":"Yuya","family":"Fujihara","sequence":"first","affiliation":[{"name":"Muta Hospital, Fukuoka, Japan"},{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Hamanoue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Iizuka Hospital, Iizuka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Akehi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"},{"name":"Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nomiyama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yanase","sequence":"additional","affiliation":[{"name":"Muta Hospital, Fukuoka, Japan"},{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Caldwell S, Argo C (2010) The natural history of non-alcoholic fatty liver disease. Dig Dis 28: 162\u2013168.","DOI":"10.1159\/000282081"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ertle J, Dech\u00eane A, Sowa JP, Penndorf V, Herzer K, et al. (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 128: 2436\u20132443.","DOI":"10.1002\/ijc.25797"},{"key":"3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"3 Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846\u2013854.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57: 1441\u20131447.","DOI":"10.1136\/gut.2007.146019"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Palekar NA, Naus R, Larson SP, Ward J, Harrison SA (2006) Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int 26: 151\u2013156.","DOI":"10.1111\/j.1478-3231.2005.01209.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43: 1317\u20131325.","DOI":"10.1002\/hep.21178"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, et al. (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7: 1104\u20131112.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Sun W, Cui H, Li N, Wei Y, Lai S, et al. (2016) Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study. Hepatol Res 46: 862\u2013870.","DOI":"10.1111\/hepr.12647"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogeneous steroids to both testosterone-binding globulin and corticosteroid-binding in human placenta. J Clin Endocrinol Metab 53: 58\u201368.","DOI":"10.1210\/jcem-53-1-58"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Zitzmann M (2009) Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5: 673\u2013681.","DOI":"10.1038\/nrendo.2009.212"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Grossmann M (2011) Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 96: 2341\u20132353.","DOI":"10.1210\/jc.2011-0118"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Rao PM, Kelly DM, Jones TH (2013) Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol 9: 479\u2013493.","DOI":"10.1038\/nrendo.2013.122"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361: 1152\u20131163.","DOI":"10.1056\/NEJMoa0804381"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT (2011) Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systemic review and meta-analysis of observational studies. Int J Epidemiol 40: 189\u2013207.","DOI":"10.1093\/ije\/dyq158"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Tanabe M, Akehi Y, Nomiyama T, Murakami J, Yanase T (2015) Total testosterone is the most valuable indicator of metabolic syndrome among various testosterone values in middle-aged Japanese men. Endocr J 62: 123\u2013132.","DOI":"10.1507\/endocrj.EJ14-0313"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Plymate SR, Jones RE, Matej LA, Friedl KE (1988) Regulation of sex hormone biding globlin (SHBG) production in Hep G2 cells by insulin. Steroids 52: 339\u2013340.","DOI":"10.1016\/0039-128X(88)90136-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Upala S (2017) Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Hepatol 16: 382\u2013394.","DOI":"10.5604\/01.3001.0009.8593"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Miyauchi S, Miyake T, Miyazaki M, Eguchi T, Niiya T, et al. (2017) Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus. Endocr J 64: 1137\u20131142.","DOI":"10.1507\/endocrj.EJ17-0225"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412\u2013419.","DOI":"10.1007\/BF00280883"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640\u20131645.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2169\/naika.94.794","volume":"94","year":"2005","unstructured":"21 The Examination Committee of Criteria for Metabolic Syndrome (2005) The definition and criteria of metabolic syndrome. Nihon Naika Gakkai Zasshi 94: 794\u2013809 (In Japanese).","journal-title":"Nihon Naika Gakkai Zasshi","ISSN":"https:\/\/id.crossref.org\/issn\/0021-5384","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Siddiqui MS, Cheang KL, Luketic VA, Boyett S, Idowu MO, et al. (2015) Nonalcoholic steatohepatitis (NASH) is associated with a decline in pancreatic beta cell (\u03b2-Cell) function. Dig Dis Sci 60: 2529\u20132537.","DOI":"10.1007\/s10620-015-3627-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, et al. (2018) Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25: 846\u2013984.","DOI":"10.5551\/jat.GL2017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Shin JY, Kim SK, Lee MY, Kim HS, Ye BI, et al. (2011) Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. Diabetes Res Clin Pract 94: 156\u2013162.","DOI":"10.1016\/j.diabres.2011.07.029"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Hua X, Sun Y, Zhong Y, Feng W, Huang H, et al. (2014) Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Clin Endocrinol (Oxf) 80: 877\u2013883.","DOI":"10.1111\/cen.12360"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zitzmann M (2009) Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5: 673\u2013681.","DOI":"10.1038\/nrendo.2009.212"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Yanase T, Fan W, Kyoya K, Min L, Takayanagi R, et al. (2008) Androgens and metabolic syndrome: lessons from androgen receptor knockout (ARKO) mice. J Steroid Biochem Mol Biol 109: 254\u2013257.","DOI":"10.1016\/j.jsbmb.2008.03.017"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Mauras N, Hayes V, Welch S, Rini A, Helgeson K, et al. (1998) Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 83: 1886\u20131892.","DOI":"10.1210\/jc.83.6.1886"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Keating NL, O\u2019Malley AJ, Smith MR (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24: 4448\u20134456.","DOI":"10.1200\/JCO.2006.06.2497"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, et al. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89: 3313\u20133318.","DOI":"10.1210\/jc.2003-031069"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Sim\u00f3 R, S\u00e1ez-L\u00f3pez C, Barbosa-Desongles A, Hern\u00e1ndez C, Selva DM (2015) Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab 26: 376\u2013383.","DOI":"10.1016\/j.tem.2015.05.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Sim\u00f3 R, Saez-Lopez C, Lecube A, Hernandez C, Fort JM, et al. (2014) Adiponectin upregulates SHBG production: molecular mechanisms and potential implications. Endocrinology 155: 2820\u20132830.","DOI":"10.1210\/en.2014-1072"},{"key":"33","unstructured":"33 Saez-Lopez C, Barbosa-Desongles A, Hernandez C, Dyer RA, Innis SM, et al. (2017) Sex hormone-binding globulin reduction in metabolic disorders may play a role in NAFLD development. Endocrinology 158: 545\u2013559."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Schwinge D, Carambia A, Quaas A, Krech T, Wegscheid C, et al. (2015) Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis. J Immunol 194: 2522\u20132530.","DOI":"10.4049\/jimmunol.1400076"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, et al. (2008) Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int 28: 519\u2013524.","DOI":"10.1111\/j.1478-3231.2007.01614.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Stefan N, Schick F, H\u00e4ring HU (2009) Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med 361: 2675\u20132676.","DOI":"10.1056\/NEJMc0910143"},{"key":"37","unstructured":"37 Flechtner-Mors M, Schick A, Oeztuerk S, Haenle MM, Wilhelm M, et al. (2014) Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1,657 subjects. Horm Metab Res 46: 287\u2013293."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Kavanagh K, Espeland MA, Sutton-Tyrrell K, Barinas-Mitchell E, El Khoudary SR, et al. (2013) Liver fat and SHBG affect insulin resistance in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN). Obesity (Silver Spring) 21: 1031\u20131038.","DOI":"10.1002\/oby.20077"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, et al. (2015) Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin Gastroenterol Hepatol 13: 1686\u20131693.","DOI":"10.1016\/j.cgh.2014.12.033"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Bonnet F, Velayoudom Cephise FL, Gautier A, Dubois S, Massart C, et al. (2013) Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features. Clin Endocrinol (Oxf) 79: 517\u2013522.","DOI":"10.1111\/cen.12089"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Yamazaki H, Kushiyama A, Sakoda H, Fujishiro M, Yamamotoya T, et al. (2018) Protective effect of sex hormone-binding globulin against metabolic syndrome: <i>in vitro<\/i> evidence showing anti-inflammatory and lipolytic effects on adipocytes and macrophages. Mediators Inflamm 2018: 3062319.","DOI":"10.1155\/2018\/3062319"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/7\/66_EJ18-0505\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T03:39:52Z","timestamp":1564803592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/7\/66_EJ18-0505\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0505","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}